Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer defined by the absence of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast cancer.